Drug Description in Trials / DrugBank / KEGG DRUG /


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1AAV BBP-631----[1] 81
2Abiraterone[1] Abiraterone---[2] 75, 81
3Abiraterone Acetate[2] Abiraterone,
Acetate
---[2] 75, 81
4Acetate[1] Acetate---[43] 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299
5ATR-101----[2] 75, 81
6Balance[1] Isoxaflutole---[8] 6, 11, 13, 81, 113, 122, 149, 299
7Behavioral: quality of life assessment----[1] 81
8Bone balance measurements[1] Isoxaflutole---[1] 81
9Chronocort----[1] 81
10Chronocort 10mg----[1] 81
11Chronocort 5mg----[1] 81
12Chronocort®----[1] 81
13Chronocort® 10 mg----[1] 81
14Chronocort® 20 mg----[1] 81
15Chronocort® 5 mg----[1] 81
16CI-984, 17AA70, PD 132301-2----[1] 81
17Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)[7] Acetate,
Cortisone,
Cortisone acetate,
Dexamethasone,
Hydrocortisone,
Prednisolone,
Prednisone
[21] D00088 ,
D00292 ,
D00472 ,
D00473 ,
D00973 ,
D00975 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D01998 ,
D02156 ,
D02174 ,
D02591 ,
D02592 ,
D03301 ,
D07749
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
18Cortef[1] Hydrocortisone cypionate[1] D00976 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 6, 81, 83
19Corticotropin[1] Corticotropin[1] D00146 [1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[9] 2, 13, 46, 75, 78, 81, 84, 205, 222
20Cortisol[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[2] 81, 98
21Cortison----[1] 81
22Cortisone[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
23Cortisone acetate[3] Acetate,
Cortisone acetate,
Hydrocortisone
[2] D00088 ,
D00973
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
24Crinecerfont----[1] 81
25Crinecerfont is a novel non-peptide selective corticotropin releasing factor 1 (CRF1 ) receptor antagonist.[1] Corticotropin[1] D00146 [1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 81
26Dectancyl----[1] 81
27Dexamethasone[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[25] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299
28Dexamethasone 0,1 mg Tablets[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
29Dexamethasone 0.5mg Tablet[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
30Dexamethasone 1,5 mg Tablets[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
31Dexamethasone 2mg Tablets[1] Dexamethasone[9] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
32DIURF-006----[1] 81
33Dual release hydrocortisone (plenadren)[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
34Efmody 10 mg modified release hard capsules[1] Manganese citrate---[1] 81
35Efmody 5 mg modified release hard capsules[1] Manganese citrate---[1] 81
36Fludrocortisone[1] Fludrocortisone[2] D00986 ,
D07967
[1] NR3C2 💬[1] Aldosterone-regulated sodium reabsorption 💬[3] 6, 17, 81
37Flutamide[1] Flutamide[1] D00586 [1] AR 💬[4] Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬[1] 81
38Hormonal balance measurements[1] Isoxaflutole---[1] 81
39Hydrocortisone[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[10] 6, 41, 46, 53, 75, 78, 81, 83, 97, 299
40Hydrocortisone (Solucortef)[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
41Hydrocortisone 10mg Tablet[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
42Hydrocortisone 10mg Tablets[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
43Hydrocortisone 20mg Tablets[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
44HYDROCORTISONE MICRONIZED[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
45Hydrocortisone Modified Release Capsules[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
46Hydrocortisone sodium acetate[3] Acetate,
Hydrocortisone,
Sodium acetate
[2] D00088 ,
D01779
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
47HYDROCORTISONE SODIUM PHOSPHATE[2] Hydrocortisone,
Phosphate ion
[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 53, 81, 83
48HYDROCORTISONE SODIUM SUCCINATE[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 81, 83, 97
49Hydrocortisone tablet 2.5 mg[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
50Hydrocortisone withdrawal[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
51HYDROCORTISONE- hydrocortisone tablet[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
52IDROCORTISONE----[1] 81
53Infacort----[1] 81
54Infacort®----[1] 81
55Insulin pump (Medtronic)----[1] 81
56Letrozole[1] Letrozole[1] D00964 [1] CYP19A1 💬[3] Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬[2] 81, 89
57Metabolic balance measurements[1] Isoxaflutole---[1] 81
58Metformin[1] Metformin[2] D00944 ,
D04966
[2] PRKAA1,
PRKAA2 💬
[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[24] 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301
59METFORMIN HYDROCHLORIDE[1] Metformin[2] D00944 ,
D04966
[2] PRKAA1,
PRKAA2 💬
[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[5] 81, 158, 265, 299, 301
60Metformine[1] Metformin[2] D00944 ,
D04966
[2] PRKAA1,
PRKAA2 💬
[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[3] 46, 81, 299
61Metformine Sandoz 850 mg filmomhulde tabletten[1] Metformin[2] D00944 ,
D04966
[2] PRKAA1,
PRKAA2 💬
[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[1] 81
62MONITOR[1] Methamidophos---[20] 2, 11, 13, 19, 28, 46, 49, 58, 65, 70, 81, 85, 86, 98, 113, 118, 129, 298, 299, 300
63National Drug Code: 59762-0074----[1] 81
64NBI-74788----[1] 81
65NBI-77860----[1] 81
66Nevanimibe[1] Nevanimibe[1] D11300 --[2] 75, 81
67Nevanimibe hydrochloride[1] Nevanimibe[1] D11300 --[2] 75, 81
68Nifedipine[1] Nifedipine[1] D00437 [4] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬
[37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[2] 50, 81
69Phosphate[1] Phosphate ion---[33] 2, 3, 6, 11, 12, 13, 15, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299
70Pioglitazone[1] Pioglitazone[2] D00945 ,
D08378
[1] PPARG 💬[11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[17] 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299
71PREDNISOLONE[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[43] 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307
72Prednisolone 1mg Tablets[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
73Prednisolone 2,5 mg Tablets[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
74Prednisolone 5 mg Tablets[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
75Prednisolone 5mg Tablet[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
76Prednisone[1] Prednisone[1] D00473 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[48] 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331
77Release[1] Manganese citrate---[12] 6, 8, 13, 46, 65, 78, 81, 96, 97, 206, 226, 299
78Sodium acetate[2] Acetate,
Sodium acetate
[1] D01779 --[1] 81
79Solu-Cortef[2] Hydrocortisone cypionate,
Hydrocortisone succinate
[2] D00976 ,
D01442
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 6, 81, 83
80SPR001----[1] 81
81Standard Care----[2] 81, 299
82Standard glucocorticoid therapy----[1] 81
83Subcutaneous hydrocortisone[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 81
84TILDACERFONT----[1] 81